Titan Pharmaceuticals (NASDAQ:TTNP) Earns Sell Rating from Analysts at StockNews.com

StockNews.com initiated coverage on shares of Titan Pharmaceuticals (NASDAQ:TTNP – Free Report) in a research note published on Monday morning. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Titan Pharmaceuticals Price Performance NASDAQ:TTNP opened at $7.10 on Monday. The firm’s 50-day moving average price is $7.34 and its 200-day moving average […]

Related Keywords

Canada , United States , , Titan Pharmaceuticals Company Profile , Millennium Management , Virtu Financial , News Ratings For Titan Pharmaceuticals Daily , European Union , Titan Pharmaceuticals , Institutional Trading Of Titan Pharmaceuticals , Titan Pharmaceuticals Inc , Renaissance Technologies , Titan Pharmaceuticals Price Performance , Nasdaq , Free Report , Street Corp , Get Free Report , Titan Pharmaceuticals Daily ,